Jaideep Chanayil Menon, D.M.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Snake Bites | 8 | 2024 | 26 | 3.550 |
Why?
|
India | 23 | 2024 | 2326 | 1.280 |
Why?
|
Snake Venoms | 3 | 2022 | 40 | 0.850 |
Why?
|
Antivenins | 4 | 2024 | 16 | 0.660 |
Why?
|
Siblings | 1 | 2021 | 826 | 0.570 |
Why?
|
Coronary Artery Disease | 3 | 2022 | 6616 | 0.450 |
Why?
|
Medication Adherence | 1 | 2024 | 2150 | 0.410 |
Why?
|
Poverty Areas | 2 | 2023 | 264 | 0.380 |
Why?
|
Cost of Illness | 5 | 2023 | 1925 | 0.340 |
Why?
|
Hypertension | 5 | 2023 | 8526 | 0.330 |
Why?
|
Diabetes Mellitus | 3 | 2022 | 5843 | 0.320 |
Why?
|
Multicenter Studies as Topic | 2 | 2024 | 1695 | 0.310 |
Why?
|
Snakes | 3 | 2022 | 29 | 0.300 |
Why?
|
Viper Venoms | 2 | 2024 | 14 | 0.290 |
Why?
|
Pandemics | 4 | 2023 | 8565 | 0.290 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2024 | 10246 | 0.290 |
Why?
|
Public Health | 1 | 2020 | 2656 | 0.280 |
Why?
|
Cardiovascular Diseases | 4 | 2024 | 15651 | 0.280 |
Why?
|
L-Amino Acid Oxidase | 1 | 2024 | 6 | 0.250 |
Why?
|
Viperidae | 1 | 2024 | 4 | 0.250 |
Why?
|
Phospholipases A2 | 1 | 2024 | 197 | 0.240 |
Why?
|
Poverty | 1 | 2015 | 2662 | 0.220 |
Why?
|
Reminder Systems | 2 | 2024 | 385 | 0.210 |
Why?
|
House Calls | 1 | 2024 | 160 | 0.210 |
Why?
|
Cross Reactions | 1 | 2024 | 815 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3080 | 0.210 |
Why?
|
Stroke | 2 | 2015 | 9904 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3200 | 0.200 |
Why?
|
Population Surveillance | 3 | 2016 | 2610 | 0.190 |
Why?
|
Rural Population | 3 | 2016 | 2246 | 0.180 |
Why?
|
Cross-Sectional Studies | 6 | 2022 | 25696 | 0.180 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 3155 | 0.170 |
Why?
|
Reptilian Proteins | 1 | 2019 | 5 | 0.170 |
Why?
|
Hypertension, Pulmonary | 2 | 2021 | 1562 | 0.170 |
Why?
|
Quality-Adjusted Life Years | 2 | 2023 | 1713 | 0.160 |
Why?
|
Blister | 1 | 2019 | 86 | 0.160 |
Why?
|
Life Expectancy | 2 | 2023 | 1248 | 0.160 |
Why?
|
Capillary Leak Syndrome | 1 | 2018 | 32 | 0.150 |
Why?
|
Smoking | 1 | 2015 | 9047 | 0.150 |
Why?
|
Telemedicine | 3 | 2024 | 2977 | 0.150 |
Why?
|
Cardiovascular Agents | 1 | 2024 | 866 | 0.150 |
Why?
|
Myocardial Infarction | 2 | 2019 | 11871 | 0.150 |
Why?
|
Humans | 28 | 2024 | 755533 | 0.130 |
Why?
|
Rural Health | 1 | 2016 | 299 | 0.120 |
Why?
|
Registries | 4 | 2021 | 8405 | 0.120 |
Why?
|
Risk Factors | 6 | 2023 | 73860 | 0.110 |
Why?
|
Culture | 1 | 2017 | 622 | 0.110 |
Why?
|
Incidence | 2 | 2022 | 21239 | 0.110 |
Why?
|
Burnout, Professional | 1 | 2022 | 685 | 0.110 |
Why?
|
Diabetic Retinopathy | 1 | 2022 | 1258 | 0.100 |
Why?
|
Socioeconomic Factors | 2 | 2017 | 7782 | 0.100 |
Why?
|
Adult | 15 | 2023 | 217986 | 0.100 |
Why?
|
Aged | 12 | 2023 | 167376 | 0.100 |
Why?
|
Cholesterol, LDL | 1 | 2021 | 2412 | 0.100 |
Why?
|
Cost-Benefit Analysis | 1 | 2024 | 5496 | 0.090 |
Why?
|
Coronary Angiography | 1 | 2022 | 4554 | 0.090 |
Why?
|
Community Health Services | 1 | 2015 | 655 | 0.090 |
Why?
|
Health Services Accessibility | 3 | 2017 | 5328 | 0.090 |
Why?
|
Morbidity | 3 | 2023 | 1762 | 0.080 |
Why?
|
Proteome | 1 | 2019 | 1835 | 0.080 |
Why?
|
Middle Aged | 14 | 2022 | 218055 | 0.080 |
Why?
|
Health Personnel | 1 | 2022 | 3281 | 0.080 |
Why?
|
Health Policy | 1 | 2020 | 2664 | 0.070 |
Why?
|
Male | 13 | 2023 | 356577 | 0.070 |
Why?
|
Female | 14 | 2023 | 387920 | 0.070 |
Why?
|
Insurance, Health | 1 | 2019 | 2498 | 0.070 |
Why?
|
Health Expenditures | 1 | 2019 | 2343 | 0.070 |
Why?
|
Health Care Costs | 1 | 2019 | 3228 | 0.060 |
Why?
|
Regression Analysis | 1 | 2015 | 6364 | 0.060 |
Why?
|
Health Surveys | 1 | 2014 | 4049 | 0.060 |
Why?
|
Hyaluronoglucosaminidase | 1 | 2024 | 135 | 0.060 |
Why?
|
Prognosis | 2 | 2022 | 29423 | 0.060 |
Why?
|
Animals | 6 | 2024 | 167149 | 0.060 |
Why?
|
Gross Domestic Product | 1 | 2023 | 76 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2017 | 3948 | 0.050 |
Why?
|
Self-Help Groups | 1 | 2022 | 189 | 0.050 |
Why?
|
Risk Assessment | 1 | 2022 | 23956 | 0.050 |
Why?
|
Species Specificity | 1 | 2024 | 2410 | 0.040 |
Why?
|
Elapid Venoms | 1 | 2019 | 41 | 0.040 |
Why?
|
Acute Coronary Syndrome | 1 | 2012 | 2361 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2024 | 64535 | 0.040 |
Why?
|
Echocardiography, Doppler | 1 | 2021 | 900 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12200 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2015 | 5290 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2024 | 3785 | 0.040 |
Why?
|
Heart Failure | 1 | 2021 | 11781 | 0.040 |
Why?
|
Lipoprotein(a) | 1 | 2022 | 494 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2019 | 58549 | 0.030 |
Why?
|
Blood Pressure | 2 | 2022 | 8494 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2022 | 79686 | 0.030 |
Why?
|
Urban Population | 1 | 2023 | 2013 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2022 | 2631 | 0.030 |
Why?
|
Cholesterol | 1 | 2022 | 2919 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2022 | 21907 | 0.030 |
Why?
|
Mental Health | 1 | 2022 | 3178 | 0.020 |
Why?
|
Prevalence | 1 | 2023 | 15589 | 0.020 |
Why?
|
Proteomics | 1 | 2019 | 3760 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2304 | 0.020 |
Why?
|
Qualitative Research | 1 | 2015 | 2907 | 0.020 |
Why?
|
Disease Management | 1 | 2015 | 2484 | 0.020 |
Why?
|
Prospective Studies | 2 | 2021 | 53991 | 0.010 |
Why?
|
Echocardiography | 1 | 2016 | 4957 | 0.010 |
Why?
|
Fibrinolytic Agents | 1 | 2012 | 2167 | 0.010 |
Why?
|
Depression | 1 | 2022 | 7961 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2015 | 3832 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12782 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12843 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2012 | 3177 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2012 | 5400 | 0.010 |
Why?
|
Infant | 1 | 2019 | 35867 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39179 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 41893 | 0.010 |
Why?
|
Hospitalization | 1 | 2012 | 10683 | 0.010 |
Why?
|
Young Adult | 1 | 2019 | 58025 | 0.010 |
Why?
|